4//SEC Filing
TITAN PHARMACEUTICALS INC 4
Accession 0001144204-15-057282
$TTNPCIK 0000910267operating
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 9:36 PM ET
Size
6.0 KB
Accession
0001144204-15-057282
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
BHONSLE SUNIL
DirectorPresident
Transactions
- Purchase
Common Stock
2015-09-28$3.62/sh+910$3,296→ 90,274 total
Holdings
- 54,684(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]All share and dollar amounts reflect a 1-for-5.5 reverse stock split effected on 9/29/15.
- [F2]Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $3.58 to $3.63. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]The reporting person serves as trustee of the family trust.
Documents
Issuer
TITAN PHARMACEUTICALS INC
CIK 0000910267
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000910267
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 9:36 PM ET
- Size
- 6.0 KB